July 23, 2025

Rethinking Uveitis

How might uveitis treatment be reconsidered in light of new evidence?

The Ophthalmologist

July 17, 2025

Preserving Vision, Preventing Loss

How can ophthalmologists empower patients to take an active role against age-related macular degeneration (AMD)?

The Ophthalmologist

July 14, 2025

Phase 1b LOTUS Trial Targets IL-6R for DME

Dr. Veeral Sheth presents promising results from a phase 1 trial of EB-105, an innovative treatment for diabetic macular edema, which may enhance patient outcomes significantly.

Retinal Physician

July 09, 2025

PXF: A Silent Threat to Vision

A study in the clinical recognition and management of pseudoexfoliation syndrome

The Ophthalmologist

July 08, 2025

Photobiomodulation for Dry AMD

PBM represents an exciting advancement in eye care for the millions of people in the United States with dry AMD. As with any new technology, some work is needed prior to introducing it in your practice.

Ophthalmic Professional

July 08, 2025

Are You Ready for a Medicare Optical Inspection?

Laurie Brown reviews the key requirements that some optical locations may have overlooked, helping you ensure full compliance.

Ophthalmic Professional

July 08, 2025

Melanomas: Clinical Decision Making with AI

Artificial intelligence support for opticians assessing small pigmented choroidal lesions

The Ophthalmologist

July 01, 2025

Getting YAG in the Bag: Tips for Success

Joe Munsell, OD, dedicated part of his 2025 Optometry’s Meeting lecture, “Optometric Laser Procedures: Pearls, Pitfalls, and How to Successfully Incorporate Into Your Practice,” to clinical pearls related to the procedure.

Optometric Management

July 01, 2025

Dr. Shannon Boye

Atsena Therapeutics’ founder and chief scientific officer discusses her role as CSO, the latest developments with ATSN-101, trends in the ocular gene therapy space, and more.

Ophthalmology Management